Page last updated: 2024-08-18

4-butyrolactone and HPV Infection

4-butyrolactone has been researched along with HPV Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adlercreutz, H; Dillner, J; Gislefoss, R; Hakama, M; Hallmans, G; Langseth, H; Lumme, S; Luostarinen, T; Saikku, P; Stattin, P; Stenman, UH; Tenkanen, L; Tuohimaa, P1

Other Studies

1 other study(ies) available for 4-butyrolactone and HPV Infection

ArticleYear
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:7

    Topics: 4-Butyrolactone; Adult; Blood Banks; Case-Control Studies; Chlamydia Infections; Chlamydia trachomatis; Cohort Studies; Finland; Human papillomavirus 18; Humans; Lignans; Longitudinal Studies; Male; Middle Aged; Norway; Papillomavirus Infections; Prostatic Neoplasms; Risk Factors; Sweden; Testosterone; Vitamin D

2016